Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Dermatology
•
Systemic autoimmune diseases
If methotrexate is contraindicated or not tolerated, what systemic treatments do you use for generalized morphea?
Related Questions
How often do you draw screening ANAs for discoid lupus?
Do you always biopsy patients who present with classic skin findings of dermatomyositis?
How do you counsel patients with dermatomyositis on sun protection?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
How do you approach management of patients with RA who have paradoxical eczematous reaction while on TNF inhibitor?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
